M&A Deal Summary

Allergan Acquires Precision Light

On August 8, 2011, Allergan acquired medical products company Precision Light for 12M USD

Acquisition Highlights
  • This is Allergan’s 4th transaction in the Medical Products sector.
  • This is Allergan’s 9th largest (disclosed) transaction.
  • This is Allergan’s 8th transaction in the United States.
  • This is Allergan’s 4th transaction in California.

M&A Deal Summary

Date 2011-08-08
Target Precision Light
Sector Medical Products
Buyer(s) Allergan
Deal Type Add-on Acquisition
Deal Value 12M USD

Target

Precision Light

Los Gatos, California, United States
Precision Light, Inc. is a medical device company it develops products for breast, body imaging systems.

Search 214,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Allergan

Irvine, California, United States

Category Company
Founded 1948
Sector Life Science
Employees11,400
DESCRIPTION

Allergan, Inc. is a pharmaceutical company. Allergan's products include ophthalmic pharmaceuticals, dermatology products, and neurological products.


DEAL STATS #
Overall 8 of 14
Sector: Medical Products M&A 4 of 6
Type: Add-on Acquisition M&A Deals 7 of 13
State: California M&A 4 of 8
Country: United States M&A 8 of 14
Year: 2011 M&A 3 of 3
Size (of disclosed) 9 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-19 Vicept Therapeutics

Malvern, Pennsylvania, United States

Vicept Therapeutics is a privately held specialty pharmaceutical company with a mission to develop the first effective topically applied therapy directed toward the erythema of rosacea and other disorders characterized by redness and or flushing of the skin. Vicept Therapeutics was founded in 2009 and is based in Malvern, Pennsylvania.

Buy $275M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-11-16 SkinMedica

Carlsbad, California, United States

SkinMedica, Inc. is a developing, acquiring and commercializing products that improve the appearance of skin. The Company markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products.

Buy $350M